MedDataX Logo

Impact of Diet on Functional Gastrointestinal Symptoms

NCT ID: NCT03102411

Last Updated: 2019-01-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1881 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-09

Study Completion Date

2017-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional survey study is to determine the prevalence of functional gastrointestinal (GI) disorders in the general population and to describe common triggers for food-related GI symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of a Low FODMAP Diet in Functional Dyspepsia Patients With Meal Related Symptoms

NCT06388330

Functional Dyspepsia FODMAP Diet
COMPLETED NA

Gut Permeability, Sensitivity and Symptomatology

NCT02358564

Irritable Bowel Syndrome Visceral Hypersensitivity
COMPLETED NA

Evaluating and Treating Potential Research Participants With Digestive Disorders

NCT01736280

Stress Irritable Bowel Syndrome Obesity +1 more
TERMINATED NA

"Functional Bowel Disorder. Investigation in General Practice"

NCT01153295

Irritable Bowel Syndrome
COMPLETED NA

Diet Reintroduction Study in Irritable Bowel Syndrome

NCT03052439

Irritable Bowel Syndrome
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Functional gastrointestinal disorders, involving symptoms such as gas/bloating, diarrhea, constipation and abdominal pain, are estimated to impact between 35 and 45 million Americans, an overwhelming 15-20% of the population. These symptoms are responsible for upwards of 20 billion dollars in healthcare costs and extensive loss of quality of life for sufferers. Moreover, many patients suffer in silence, with 67% of subjects waiting more than a year before treatment, and 11% waiting over 10 years. Irritable bowel syndrome is the most prevalent functional gastrointestinal disorder, and several recent studies support the idea that dietary modifications may be key to alleviating this condition.

The purpose of this study is to document gastrointestinal symptoms among the US population, as well as to ascertain awareness and utilization of dietary treatments that exist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Disorder, Functional

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Exclusion Criteria

* Visual impairment
* Inability to read
* Inability to understand English
* Inability to use a computer to respond to questions.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TriHealth Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rachel Pauls, MD

Role: PRINCIPAL_INVESTIGATOR

TriHealth - Cincinnati Urogynecology Associates

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cincinnati Urogynecology Associates

Cincinnati, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity
NCT05056610 COMPLETED NA
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 UNKNOWN PHASE4
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
NCT03266068 COMPLETED
Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship With IBS Symptoms and the Degree of Self-assessed Physical Activity
NCT05293769 RECRUITING
Probiotics and Gut Health
NCT01874301 COMPLETED NA
The Association of Clinical Symptom Clusters With Underlying Mechanisms in Functional Gastrointestinal Disorders
NCT04331223 COMPLETED
Treatment of Functional Bowel Disorders
NCT00006157 COMPLETED PHASE3
Mediterranean Diet and the Gut Microbiome
NCT03269032 COMPLETED NA
Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity
NCT05795049 ACTIVE_NOT_RECRUITING
Identification of Gluten Sensitivity in Irritable Bowel Syndrome
NCT04017585 COMPLETED NA
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
NCT02980406 COMPLETED NA
Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
NCT04853381 COMPLETED NA
Treatment of Constipation in Functional Dyspepsia
NCT02956187 COMPLETED NA
Low FODMAP Diet in FD (PDS)
NCT05832528 RECRUITING NA
Efficacy of the DOMINO Diet App in IBS
NCT05808036 RECRUITING NA
Elemental Diet and Gut Microbiome
NCT05978973 COMPLETED NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814 RECRUITING NA
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 COMPLETED NA
Prevalence of FODMAP Intolerance and JHS in FGID and Association With Microbiome, Dyssynergic Defecation and Dietary Intervention
NCT03460613 COMPLETED NA
Enabling Microbiomics- Driven Personalized Nutrition
NCT06657001 ENROLLING_BY_INVITATION
Evaluation of Dietary Supplementation in Patients With Gastrointestinal Disorders.
NCT06960941 NOT_YET_RECRUITING NA
Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome
NCT02372201 COMPLETED NA
Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
NCT04060121 COMPLETED
Clinical Improvement and in Quality of Life-Functional Dyspepsia-
NCT01802710 COMPLETED NA
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
NCT04283487 COMPLETED NA